Latest filing published 22 Jun 2022 for Hansa Biopharma AB.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Donato Spota: trading record in brief
This profile gathers the share dealings of Donato Spota in Hansa Biopharma AB. We count 2 filings, every one of them for a trade on 17 June 2022.
In open-market terms, that means 1 purchase on one side and 1 sale worth €22k on the other. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 22 June 2022, reports an open-market purchase in Hansa Biopharma AB. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Donato Spota
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,311 shares0AktieISIN SE0002148817FI:csv-d26937d879ba571263a3Canonical exit: 15 Sept 2022 (T+90)
- 4,638 shares@ SEK 49.99100.0% of flowAktieISIN SE0002148817FI:csv-48fd2d7d76b379a97b00
2 of 2 declarations